Thromb Haemost 1986; 55(03): 366-368
DOI: 10.1055/s-0038-1661565
Original Article
Schattauer GmbH Stuttgart

The von Willebrand Factor in Myocardial Infarction and Unstable Angina: A Kinetic Study

Tamara Margulis
2   The Department of Cardiology, Lady Davis Carmel Hospital, Haifa, Israel
,
Miriam David
1   The Hematology Unit, Lady Davis Carmel Hospital, Haifa, Israel
,
N Maor
2   The Department of Cardiology, Lady Davis Carmel Hospital, Haifa, Israel
,
G A Soff
3   The Institute of Hematology, Tel Aviv Medical Center, Ichilov Hospital, Tel Aviv, Israel.
,
E Grenadier
2   The Department of Cardiology, Lady Davis Carmel Hospital, Haifa, Israel
,
A Palant
2   The Department of Cardiology, Lady Davis Carmel Hospital, Haifa, Israel
,
Esther Aghai
1   The Hematology Unit, Lady Davis Carmel Hospital, Haifa, Israel
› Author Affiliations
Further Information

Publication History

Received 29 October 1985

Accepted 04 April 1986

Publication Date:
18 July 2018 (online)

Summary

Recent studies have demonstrated elevations of von Willebrand Factor following acute myocardial infarction (AMI). In order to determine if this parameter may serve as a marker for AMI, we tested the blood levels of vWF and Factor VIII :C in 28 patients with AMI, 9 patients with unstable angina, 7 patients with atypical chest pain, and 25 healthy volunteers. The level of ristocetin cofactor activity of vWF was between 70 and 144% in the control group. In patients with AMI, the mean level of this activity was 175% on the first day following infarction, rose to a peak of 270% on the fifth and sixth days, and was still significantly greater than normal in all patients on the 14th day. The vWF: Ag level closely paralleled the rise of ristocetin cofactor activity of vWF, with a peak of 336% on day 5. FVIII :C was not significantly changed. No significant elevation of vWF was observed in patients with unstable angina. The ristocetin cofactor activity of vWF and vWF: Ag thus are sensitive biochemical indicators for recent AMI, and may serve as useful markers for up to 14 days following infarction, when the traditional enzymes have returned to normal levels.

 
  • References

  • 1 Cucuianu MP, Missits L, Olinic N, Roman S. Increased ristocetin cofactor in acute myocardial infarction: a component of the acute phase reaction. Thromb Haemostas 1980; 43: 41-44
  • 2 Lombardi R, Mannucci PM, Seghatchian MJ, Vicente Gozcie V, Coppola L. Alterations of Factor VIII von Willebrand Factor in clinical conditions associated with an increase in its plasma concentration. Br J Haematol 1981; 49: 61-68
  • 3 Rasi V, Torstile I, Ikkala E. β-Thromboglobin in Acute Myocardial Infarction. Acta Med Scand Suppl 1980 642. 85-91
  • 4 Hoyer LW. The Factor VIII complex. Structure and function review Blood 1981; 58: 1-13
  • 5 Zimmerman TS, Ruggeri ZM. von Willebrand’s disease. Clinics in Haematology 1983; 12: 175-200
  • 6 Tuddenham EGD, Lazarchick J, Hoyer LW. Synthesis and release of Factor VIII by cultured human endothelial cells. Br J Haematol 1981; 47: 617-626
  • 7 Ramsey R, Evatt BL. Rapid assay for von Willebrand factor activity using formalin-fixed platelets and microtitration technique. Am J Clin Path 1979; 72: 996-999
  • 8 Ness PM, Perkins HA. A simple enzyme immunoassay (ElA) test for Factor VUI-related antigen (VIII:Ag). Thromb Haemostas 1979; 42: 848-854
  • 9 Bowie EJW, Thompson JH, Didishein P, Owen CA. Mayo Clinic Laboratory Manual of Hemostasis. W B Saunders Company, Philadelphia 1971: 111-113
  • 10 Saleem A, Krieg AF, Fretz K. Improved micromethod for plasma fibrinogen unaffected by heparin therapy. Am J Clin Pathol 1975; 63: 426-433
  • 11 Grenadier D, Keidar S, Kahana L. et al The roles of serum myoglobin, total CPK and CPK-MB isoenzyme in the acute phase of myocardial infarction. Am Heart J 1983; 105: 408-416
  • 12 Goldberg DM, Windfeld DA. A diagnostic accuracy of serum enzyme assay for myocardial infarction in general hospital population. Brit Heart J 1972; 34: 597-604
  • 13 Vasudevan G, Mercer DW, Varat MA. Lactic dehydromenas isoenzyme determination in the diagnosis of acute myocardial infarction. Circulation 1978; 57: 1055-1057
  • 14 Wrobelski LD. Lactic dehydrogenase activity in blood. Proc Soc Exp Biol 1955; 90: 210-214
  • 15 Dinarello CA. Interleukin 1 and the pathogenesis of the acute phase response. New Engl J Med 1984; 311: 1413-1418
  • 16 Bertel O, Biihler FR, Baitsch G, Ritz R, Burkart F. Plasma adrenalin and noradrenalin in patients with acute myocardial infarction. Chest 1982; 82: 64-68